Terms: = Kidney tumors AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4 AND Treatment
7 results:
1. Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) and their Role in the treatment of Cancer: A Review.
Unnisa A; Chettupalli AK; Hussain T; Kamal MA
Anticancer Agents Med Chem; 2022; 22(20):3370-3381. PubMed ID: 35400324
[TBL] [Abstract] [Full Text] [Related]
2. Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas.
Zhang Q; Liu JH; Liu JL; Qi CT; Yan L; Chen Y; Yu Q
BMC Cancer; 2019 Nov; 19(1):1044. PubMed ID: 31690270
[TBL] [Abstract] [Full Text] [Related]
3. Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical Trials.
O'Connor JM; Fessele KL; Steiner J; Seidl-Rathkopf K; Carson KR; Nussbaum NC; Yin ES; Adelson KB; Presley CJ; Chiang AC; Ross JS; Abernethy AP; Gross CP
JAMA Oncol; 2018 Aug; 4(8):e180798. PubMed ID: 29800974
[TBL] [Abstract] [Full Text] [Related]
4. Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach.
Fiorentino M; Gruppioni E; Massari F; Giunchi F; Altimari A; Ciccarese C; Bimbatti D; Scarpa A; Iacovelli R; Porta C; Virinder S; Tortora G; Artibani W; Schiavina R; Ardizzoni A; Brunelli M; Knuutila S; Martignoni G
Oncotarget; 2017 Jan; 8(5):7328-7335. PubMed ID: 27741505
[TBL] [Abstract] [Full Text] [Related]
5. Clinical Pharmacokinetics and Pharmacodynamics of Afatinib.
Wind S; Schnell D; Ebner T; Freiwald M; Stopfer P
Clin Pharmacokinet; 2017 Mar; 56(3):235-250. PubMed ID: 27470518
[TBL] [Abstract] [Full Text] [Related]
6. Neuregulin-1 Administration Protocols Sufficient for Stimulating Cardiac Regeneration in Young Mice Do Not Induce Somatic, Organ, or Neoplastic Growth.
Ganapathy B; Nandhagopal N; Polizzotti BD; Bennett D; Asan A; Wu Y; Kühn B
PLoS One; 2016; 11(5):e0155456. PubMed ID: 27175488
[TBL] [Abstract] [Full Text] [Related]
7. Met, the hepatocyte growth factor receptor, localizes to the nucleus in cells at low density.
Pozner-Moulis S; Pappas DJ; Rimm DL
Cancer Res; 2006 Aug; 66(16):7976-82. PubMed ID: 16912172
[TBL] [Abstract] [Full Text] [Related]
